Apyx Medical (APYX) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $2.55, -0.39% vs the prior close of $2.56.
- Volume 53.99K shares, 0.4x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
APYX dips 0.4% to $2.55, 4 down days in a row. Closed at $2.55, -0.39% vs the prior close of $2.56. Day range $2.54–$2.65, opened at $2.60.
APYX daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — APYX dips 0.4% to $2.55, 4 down days in a row
- Closed at $2.55, -0.39% vs the prior close of $2.56. Day range $2.54–$2.65, opened at $2.60.
- Volume was 53.99K shares, 0.4x its 50-day average of 150.23K — lighter than usual.
- Price is -12.3% vs its 50-day average ($2.91) and -30.3% vs its 200-day average ($3.66).
- 52-week range $2.32–$5.08; today's close sits at 8% of that range, 49.8% below the 52-week high.
- That makes 4 straight losses.
Oct 15, 2026 — APYX dips 0.4% to $2.56, 3 down days in a row
- Closed at $2.56, -0.39% vs the prior close of $2.57. Day range $2.45–$2.58, opened at $2.45.
- Volume was 151.90K shares, 1.0x its 50-day average of 147.56K.
- Price is -12.9% vs its 50-day average ($2.94) and -30.1% vs its 200-day average ($3.66).
- 52-week range $2.32–$5.08; today's close sits at 9% of that range, 49.6% below the 52-week high.
- That makes 3 straight losses.
Oct 14, 2026 — APYX dips 1.2% to $2.57
- Closed at $2.57, -1.15% vs the prior close of $2.60. Day range $2.49–$2.59, opened at $2.59.
- Volume was 38.70K shares, 0.3x its 50-day average of 148.25K — lighter than usual.
- Price is -13.5% vs its 50-day average ($2.97) and -29.9% vs its 200-day average ($3.67).
- 52-week range $2.32–$5.08; today's close sits at 9% of that range, 49.4% below the 52-week high.
Oct 13, 2026 — APYX dips 1.9% to $2.60
- Closed at $2.60, -1.89% vs the prior close of $2.65. Day range $2.48–$2.68, opened at $2.68.
- Volume was 148.80K shares, 1.0x its 50-day average of 148.31K.
- Price is -13.5% vs its 50-day average ($3.01) and -29.2% vs its 200-day average ($3.67).
- 52-week range $2.32–$5.08; today's close sits at 10% of that range, 48.8% below the 52-week high.
Oct 12, 2026 — APYX rises 2.3% to $2.65
- Closed at $2.65, +2.32% vs the prior close of $2.59. Day range $2.53–$2.73, opened at $2.62.
- Volume was 80.00K shares, 0.5x its 50-day average of 148.37K — lighter than usual.
- Price is -12.8% vs its 50-day average ($3.04) and -27.9% vs its 200-day average ($3.68).
- 52-week range $2.32–$5.08; today's close sits at 12% of that range, 47.8% below the 52-week high.
Oct 9, 2026 — APYX jumps 9.7% to $2.59
- Closed at $2.59, +9.75% vs the prior close of $2.36. Day range $2.38–$2.62, opened at $2.38.
- Volume was 103.50K shares, 0.7x its 50-day average of 147.83K.
- Price is -15.5% vs its 50-day average ($3.07) and -29.6% vs its 200-day average ($3.68).
- 52-week range $2.32–$5.08; today's close sits at 10% of that range, 49.0% below the 52-week high.
Oct 8, 2026 — APYX slides 7.5% to $2.36, a 52-week low
- Closed at $2.36, -7.45% vs the prior close of $2.55. Day range $2.34–$2.54, opened at $2.54.
- Volume was 231.40K shares, 1.6x its 50-day average of 144.09K.
- Price is -23.8% vs its 50-day average ($3.10) and -36.0% vs its 200-day average ($3.69).
- 52-week range $2.32–$5.08; today's close sits at 1% of that range, 53.5% below the 52-week high.
Oct 7, 2026 — APYX ends flat (+0.2%) to $2.55
- Closed at $2.55, +0.20% vs the prior close of $2.55. Day range $2.49–$2.60, opened at $2.52.
- Volume was 34.80K shares, 0.2x its 50-day average of 144.64K — lighter than usual.
- Price is -18.5% vs its 50-day average ($3.13) and -30.9% vs its 200-day average ($3.69).
- 52-week range $2.32–$5.08; today's close sits at 8% of that range, 49.8% below the 52-week high.
Oct 6, 2026 — APYX dips 2.1% to $2.55
- Closed at $2.55, -2.12% vs the prior close of $2.60. Day range $2.53–$2.63, opened at $2.63.
- Volume was 129.30K shares, 0.9x its 50-day average of 143.48K.
- Price is -19.3% vs its 50-day average ($3.15) and -31.2% vs its 200-day average ($3.70).
- 52-week range $2.32–$5.08; today's close sits at 8% of that range, 49.9% below the 52-week high.
Oct 5, 2026 — APYX rises 2.0% to $2.60, 3 up days in a row
- Closed at $2.60, +1.96% vs the prior close of $2.55. Day range $2.50–$2.63, opened at $2.53.
- Volume was 68.40K shares, 0.5x its 50-day average of 143.15K — lighter than usual.
- Price is -18.2% vs its 50-day average ($3.18) and -29.8% vs its 200-day average ($3.70).
- 52-week range $2.07–$5.08; today's close sits at 18% of that range, 48.8% below the 52-week high.
- That makes 3 straight gains.
Oct 2, 2026 — APYX rises 2.0% to $2.55
- Closed at $2.55, +2.00% vs the prior close of $2.50. Day range $2.50–$2.60, opened at $2.51.
- Volume was 51.70K shares, 0.4x its 50-day average of 142.50K — lighter than usual.
- Price is -20.5% vs its 50-day average ($3.21) and -31.2% vs its 200-day average ($3.71).
- 52-week range $2.06–$5.08; today's close sits at 16% of that range, 49.8% below the 52-week high.
APYX latest news & SEC filings
Every SEC filing by or about APYX in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 29, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Aug 7, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
- Item 5.07 — Reported shareholder vote results.
Aug 6, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $13.88M (prior year $11.37M) (+22.1% vs Jun 30, 2025)
- Net income: -$3.24M (prior year -$3.78M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$0.07 (prior year -$0.09) (loss narrowed vs Jun 30, 2025)
Aug 6, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 24, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Jul 21, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 2, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jun 26, 2026 · Form DEF 14A — Proxy statement
Proxy statement — agenda for the shareholder meeting (board elections, executive pay, votes)
Things to know before you trade APYX
- Last results release: Aug 6, 2026 (8-K Item 2.02). Previous ones: May 7, 2026, Mar 10, 2026, Jan 12, 2026. Based on that rhythm, the next report is likely around Nov 5, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 3.59% (largest 15.5%). That is a volatile stock.
- Liquidity: about 163.10K shares (≈$415.92K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $2.55 vs a range of $2.32–$5.08 (8% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 8-K Sep 29, 2026; 8-K Aug 7, 2026; 10-Q Aug 6, 2026.
- Share count: 42.12M shares outstanding (Aug 5, 2026), +11.4% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Surgical & Medical Instruments & Apparatus.
APYX market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 2.60 | 2.65 | 2.54 | 2.55 | 53.99K |
| Oct 15, 2026 | 2.45 | 2.58 | 2.45 | 2.56 | 151.90K |
| Oct 14, 2026 | 2.59 | 2.59 | 2.49 | 2.57 | 38.70K |
| Oct 13, 2026 | 2.68 | 2.68 | 2.48 | 2.60 | 148.80K |
| Oct 12, 2026 | 2.62 | 2.73 | 2.53 | 2.65 | 80.00K |
| Oct 9, 2026 | 2.38 | 2.62 | 2.38 | 2.59 | 103.50K |
| Oct 8, 2026 | 2.54 | 2.54 | 2.34 | 2.36 | 231.40K |
| Oct 7, 2026 | 2.52 | 2.60 | 2.49 | 2.55 | 34.80K |
| Oct 6, 2026 | 2.63 | 2.63 | 2.53 | 2.55 | 129.30K |
| Oct 5, 2026 | 2.53 | 2.63 | 2.50 | 2.60 | 68.40K |
| Oct 2, 2026 | 2.51 | 2.60 | 2.50 | 2.55 | 51.70K |
| Oct 1, 2026 | 2.46 | 2.62 | 2.42 | 2.50 | 294.90K |
| Sep 30, 2026 | 2.58 | 2.83 | 2.45 | 2.45 | 639.60K |
| Sep 29, 2026 | 2.63 | 2.65 | 2.46 | 2.60 | 338.50K |
| Sep 28, 2026 | 2.90 | 2.95 | 2.32 | 2.50 | 362.30K |
| Sep 25, 2026 | 2.85 | 2.97 | 2.85 | 2.96 | 131.40K |
| Sep 24, 2026 | 2.96 | 2.96 | 2.83 | 2.83 | 73.80K |
| Sep 23, 2026 | 2.92 | 2.96 | 2.89 | 2.95 | 86.10K |
| Sep 22, 2026 | 2.93 | 2.98 | 2.91 | 2.95 | 73.90K |
| Sep 21, 2026 | 3.06 | 3.08 | 2.86 | 2.91 | 169.10K |
About Apyx Medical
Apyx Medical (APYX) is listed on the Nasdaq and classified by the SEC under “Surgical & Medical Instruments & Apparatus”. Its business address is in CLEARWATER, FL. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 719135.
APYX board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Minnie Baylor-Henry | Director | Jun 15, 2026 |
| Charles D. Ii Goodwin | Chief Executive Officer | Jun 15, 2026 |
| Wendy Lauren Levine | Director | Jun 15, 2026 |
| Stavros G. Vizirgianakis | Director | Jun 15, 2026 |
| Lawrence Waldman | Director | Jul 2, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Moshe Citronowicz | Sr. V.P. of Operations | Jun 15, 2026 |
| Charles D. Ii Goodwin | Chief Executive Officer | Jun 15, 2026 |
| Matthew C Hill | Chief Financial Officer | Jun 15, 2026 |
| Shawn David Roman | Chief Operating Officer | Jun 17, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
APYX financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $52.84M | $-11.21M | — | $-8.00M |
| Dec 31, 2024 | $48.10M | $-23.46M | — | $-18.05M |
| Dec 31, 2023 | $52.35M | $-18.71M | -0.54 | $-5.25M |
| Dec 31, 2022 | $44.51M | $-23.18M | -0.67 | $-20.28M |
| Dec 31, 2021 | $48.52M | $-15.17M | -0.44 | $-10.45M |
Latest balance sheet: total assets $61.07M, total liabilities $49.98M, cash $27.62M (as of Jun 30, 2026).
APYX earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 6, 2026 | 8-K Item 2.02 (results) | $4.16 |
| May 7, 2026 | 8-K Item 2.02 (results) | $3.56 |
| Mar 10, 2026 | 8-K Item 2.02 (results) | $3.45 |
| Jan 12, 2026 | 8-K Item 2.02 (results) | $4.01 |
| Nov 6, 2025 | 8-K Item 2.02 (results) | $3.35 |
| Aug 7, 2025 | 8-K Item 2.02 (results) | $1.96 |
| May 8, 2025 | 8-K Item 2.02 (results) | $1.18 |
| Mar 13, 2025 | 8-K Item 2.02 (results) | $1.04 |
| Jan 13, 2025 | 8-K Item 2.02 (results) | $1.49 |
| Nov 8, 2024 | 8-K Item 2.02 (results) | $1.52 |
| Aug 8, 2024 | 8-K Item 2.02 (results) | — |
| May 9, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Surgical & Medical Instruments & Apparatus
Boston Scientific (BSX)Stryker (SYK)3M (MMM)Dexcom (DXCM)Medline (MDLN)Becton Dickinson (BDX)MiniMed (MMED)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on APYX
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.